Unproven Peptides Championed by RFK Jr. Can Now Be Made by Compounders
News

Controversial Peptide Drugs Championed by RFK Jr. Will Now Be Easier to Get

A new policy from the Department of Health and Human Services will temporarily allow compounding pharmacies to prepare and sell 6 controversial products.
Controversial Peptide Drugs Championed by RFK Jr. Will Now Be Easier to Get
Adobe Stock

Compounding pharmacies can now temporarily manufacture select peptide products from bulk ingredients, according to a new policy quietly adopted by the U.S. Department of Health and Human Services (HHS).

The move improves access to six controversial peptides championed by wellness influencers and HHS's secretary, Robert F. Kennedy Jr. But it does not mean that these substances are safe or effective, as they have not been approved by the FDA.

Nor does the decision mean that it's legal for compounders to manufacture these peptides. Instead, HHS will exercise “enforcement discretion,” meaning the agency will look the other way when compounding pharmacies make and sell these products.

An industry group representing compounding pharmacies frames the move as positive for public health, given the number of Americans who are buying these peptides from unlicensed “gray market” providers, seeking to boost their health and longevity.

“Right now, far too many patients are obtaining peptides from illicit suppliers with little assurance about what’s actually in the vial,” the Alliance for Pharmacy Compounding said in a statement released Thursday. “That’s an existing public health threat, and one that isn’t going away simply because compounding of the substances is prohibited.”

Allowing licensed pharmacies to prepare these medications “offers a more accountable alternative,” the statement reads.

But doctors have serious concerns. “This is dangerous. These ‘peptides’ are not known to be safe and effective in humans — full stop,” says Jamie Alan, PharmD, PhD, an associate professor of pharmacology and toxicology at Michigan State University in East Lansing. “People will be hurt, and people will probably die.”

What Are Peptides, and Which Ones Can People Now Buy From Compounders?

“Peptide” is a broad term that can apply to many different substances, Dr. Alan says. From a medical perspective, peptides are links of amino acids. They typically consist of a sequence of 2 to 50 amino acids.

Many drugs and medications are classified as peptides, including FDA-approved insulin and GLP-1s like Ozempic. But the peptides covered in the latest HHS policy haven’t undergone the safety and efficacy testing required by the FDA to obtain approval for human use.

The following peptides can now be manufactured by compounding pharmacies, according to the new HHS policy. Their recommended uses, as discussed at an advisory committee meeting in July, are unproven by rigorous scientific standards.

  • BPC-157 for ulcerative colitis
  • Epitalon for insomnia
  • KPV for wound healing and inflammatory conditions
  • MOTS-c for obesity and osteoporosis
  • Semax for migraine, cerebral ischemia, and trigeminal neuralgia
  • TB-500 for wound healing

Does the New Rule Mean These Peptides Are Safe?

No, the new rule does not mean that these peptides are safe.

“Demonstrating efficacy and safety of an investigational drug is a rigorous, arduous process for ultimately one reason: Do no harm to patients,” says Arindam Bhattacharjee, PhD, a professor of pharmacology and toxicology at the State University of New York at Buffalo. “That is why clinical trials are extensive — and expensive — and the FDA uses concrete data to ultimately make the decision whether to approve a new drug or not.”

The peptides listed by this new HHS policy “have not gone under the typical rigorous testing of clinical trials,” Dr. Bhattacharjee says. He calls the act of bypassing the FDA “dangerous,” adding, “The FDA’s mission is to protect the public and the well-being of patients who are taking drugs.”

The HHS decision is not backed by any new research on these peptides, and the new policy does not claim the peptides are safe and effective. HHS “is just saying they won’t take action if compounders make this, which is not the same as saying this is safe and it works,” Alan says.

The new HHS rule does have some guardrails, Bhattacharjee says. “The ingredients used to make these peptides must come exclusively from FDA-registered factories,” he says. “The final product must undergo stringent chemical identity and purity testing.”

Alan recommends that people think about using peptides this way: “If they are so safe and effective, why isn’t big pharma already selling them?” Alan also recommends being wary of any compounding pharmacies that sell these peptides, licensed or not. “I would not buy this from anyone who thinks it is ethical to engage in compounding of a product that we do not have adequate safety data on,” she says.

Do You Need a Prescription to Get One of These Peptides?

The peptides “must be compounded based on the receipt of a valid patient-specific prescription,” per the HHS policy.

Federal law, including Section 503A of the Federal Food, Drug, and Cosmetic Act, says that traditional compounding pharmacies require a valid prescription written by a licensed healthcare provider for an identified individual patient, Alan says.

“However, special registered outsourcing facilities are permitted to compound certain products without a patient-specific prescription when fulfilling direct orders for hospital or clinic office stock,” she says. “This means you might see [these peptides] in provider offices and/or med spas and would not need a prescription there.”

It’s Important to Speak to Your Doctor First

Most people use peptides to address a health issue, and asking your provider about these drugs may open the door to conversations about scientifically proven treatments.

“Please talk to your healthcare provider,” Alan says. “Even if you plan to take peptides against medical advice, at least have an honest conversation so that your provider can help keep you safe.”

Among other things, peptides may interact with other medications you’re on, making it crucial to disclose their use to your doctor, Bhattacharjee says.

Ultimately, Alan says that peptide use is a “buyer beware situation.”

EDITORIAL SOURCES
Everyday Health follows strict sourcing guidelines to ensure the accuracy of its content, outlined in our editorial policy. We use only trustworthy sources, including peer-reviewed studies, board-certified medical experts, patients with lived experience, and information from top institutions.
Resources
  1. HHS Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances. U.S. Department of Health and Human Services. October 28, 2026.
  2. Peptide. National Human Genome Research Institute. October 29, 2026.
  3. Perrone M. The Trend of Unproven Peptides Is Spreading Through Influencers and RFK Jr. Allies. AP. November 14, 2025.
  4. July 23-24, 2026: Meeting of the Pharmacy Compounding Advisory Committee. U.S. Food and Drug Administration. August 6, 2026.
  5. Human Drug Compounding Laws. U.S. Food and Drug Administration.

Emily Kay Votruba

Fact-Checker
Emily Kay Votruba has copy edited and fact-checked for national magazines, websites, and books since 1997, including Self, GQ, Gourmet, Golf Magazine, Outside, Cornell University P...
Korin Miller

Korin Miller

Author

Korin Miller is a health journalist with more than a decade of experience in the field. She covers a range of health topics, including nutrition, recent research, wellness, fitness...